All News
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer
(MedPage Today) -- Patients with metastatic urothelial carcinoma who achieved a complete response after more than 8.
Read MoreUK’s unhealthy food habits cost £268bn a year, report finds
Exclusive: Food, Farming and Countryside Commission added up cost to NHS and economy of diet-linked diseaseThe UK’s growing addiction to unhealthy food costs £268bn a year, far outstripping the bud
Read MoreMEK Inhibitor Scores Big Win in Adults, Children With Neurofibromatosis Type 1
(MedPage Today) -- Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor mirdametinib, a large multicenter study of the rare condition
Read MoreNew Brunswick premier calls on Canadian government to investigate mysterious brain illness
Previous provincial government said most patients were misdiagnosed and instead had dementia or cancerThe newly elected premier of New Brunswick has called on Canada’s federal government to aid in a
Read MoreHow Often Do Doctors Use New Weight-Loss Drugs in Kids?
(MedPage Today) -- This story is part of a series called "Ozempic: Weighing the Risks and Benefits." It was produced in part through a grant from the NIHCM Foundation.
Read MoreMike Pence urges Senate Republicans to reject RFK Jr for US health secretary
Ex-vice-president rebukes Kennedy’s stance on abortion while Matt Gaetz, another Trump pick, faces ‘uphill battle’US politics live – latest updatesMike Pence, the former vice-president, urged
Read MoreWhy Kennedy Sees an ‘Epidemic’ of Chronic Disease Among Children
Trends in child health are in fact worrisome, and scientists welcome a renewed focus on foods and environmental toxins. But vaccines and fluoride are not the cause.
Read MoreVoluntary registers and regulation in psychotherapy | Letters
Jon Levett notes the importance of checking a therapist’s credentials and the action that can be taken, while Stephanie Calman says it would be useful to have one official licensing and regulation b
Read MoreCovid is no laughing matter when it continues to hurt so many | Letters
Dr Elke Hausmann and Sue Hewison respond to Tim Dowling’s column about his sons testing positiveThank you, Tim Dowling, for exposing how even the few people who still dare to say the word “Covid�
Read MoreNMO Drug Looks Good for IgG4-Related Disease
(MedPage Today) -- WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for neuromyelitis optica (NMO), in a pivotal clinical trial.
Read More